Safety and Efficacy of Autologous iNSC-DAP in the Treatment of Parkinson's Disease
Safety and Efficacy of Autologous iNSC-DAP in the Treatment of Parkinson's Disease
Recruiting · NCT05901818 · Registry updated 2026-07-01Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety and Efficacy of Autologous iNSC-DAP in the Treatment of Parkinson's Disease | Parkinson disease, basal ganglia disorder, brain disorder, central nervous system disorder, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, synucleinopathy | Recruiting | Phase 1 | 2026-07-01 | NCT05901818 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Xuanwu Hospital, Beijing | 232 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Xuanwu Hospital Capital Medical University | Beijing | China | 22 |